Chemical activators of Vmn2r118 can engage various signalling pathways to elicit their effects. Forskolin is a potent activator of adenylyl cyclase, thereby increasing the intracellular levels of cyclic AMP (cAMP), a second messenger that is pivotal in the activation of protein kinase A (PKA). PKA can phosphorylate target proteins, including Vmn2r118, leading to its functional activation. Similarly, Isoproterenol, a beta-adrenergic agonist, enhances cAMP production through the stimulation of adenylyl cyclase which activates PKA. Upon activation, PKA can phosphorylate Vmn2r118 directly, resulting in its activation. Epinephrine, which binds to adrenergic receptors, also induces adenylyl cyclase activity, raising cAMP concentrations. The ensuing PKA activation then phosphorylates Vmn2r118, triggering its activation. Histamine, through its action on H2 receptors, stimulates Gs proteins that are coupled to adenylyl cyclase, leading to increased cAMP and subsequent PKA-mediated activation of Vmn2r118.
Dopamine interacts with D1-like receptors that activate adenylyl cyclase through Gs proteins, leading to PKA activation which then phosphorylates and activates Vmn2r118. Glucagon similarly exerts its effects by binding to its specific receptor, subsequently engaging Gs proteins that activate adenylyl cyclase, raising cAMP levels, and activating PKA, which in turn phosphorylates and activates Vmn2r118. Inhibitors of phosphodiesterases like IBMX, Rolipram, Cilostamide, and Anagrelide result in elevated cAMP levels by preventing the breakdown of cAMP to its inactive form. The resulting sustained activity of PKA can phosphorylate Vmn2r118, leading to its activation. Prostaglandin E1 (Alprostadil) activates adenylyl cyclase via E-prostanoid receptors and Gs proteins, which increases cAMP and activates PKA, subsequently leading to the phosphorylation and activation of Vmn2r118. Lastly, Vinpocetine, by inhibiting phosphodiesterase-1, causes an increase in cAMP, which activates PKA, and this kinase then activates Vmn2r118 through phosphorylation. Each of these chemicals, through their unique interactions with cellular signaling pathways, ultimately promotes the activation of Vmn2r118 in a specific manner.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts as a beta-adrenergic agonist increasing cAMP levels via adenylyl cyclase activation and subsequent PKA activation, which can phosphorylate and activate Vmn2r118. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Binds to adrenergic receptors, leading to adenylyl cyclase activation, increasing cAMP, thus activating PKA which is known to phosphorylate and activate Vmn2r118. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Activates H2 receptors which are coupled to Gs proteins that stimulate adenylyl cyclase, thereby increasing cAMP and activating PKA, causing activation of Vmn2r118. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Interacts with D1-like receptors which engage Gs proteins to activate adenylyl cyclase, resulting in increased cAMP and PKA activation that can activate Vmn2r118. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases leading to an increase in cAMP levels, thus sustaining PKA activity which is necessary for the activation of Vmn2r118. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selectively inhibits phosphodiesterase-4, causing an increase in cAMP levels which activates PKA. PKA then can phosphorylate and activate Vmn2r118. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Inhibits phosphodiesterase-3, leading to elevated cAMP levels and sustained PKA activity, which can result in the activation of Vmn2r118. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
By inhibiting phosphodiesterase-3, it increases cAMP concentration, thereby activating PKA, which in turn can phosphorylate and activate Vmn2r118. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Binds to E-prostanoid receptors and activates adenylyl cyclase via Gs proteins, increasing cAMP and activating PKA, leading to the activation of Vmn2r118. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Inhibits phosphodiesterase-1 which leads to increased cAMP levels and the subsequent activation of PKA. PKA can then activate Vmn2r118 through phosphorylation. | ||||||